Fir Tree Capital Management’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

Fir Tree Capital Management’s Portfolio EBAC Stock Details EBAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-106,300	Closed	-$1.07M	–	359
2022 Q4	$1.07M	Hold	106,300	–	–	0.06%	288
2022 Q3	$1.05M	Hold	106,300	–	–	0.04%	386
2022 Q2	$1.04M	Sell	106,300 -43,700	-29%	-$428K	0.03%	409
2022 Q1	$1.46M	Hold	150,000	–	–	0.04%	401
2021 Q4	$1.45M	Hold	150,000	–	–	0.04%	402
2021 Q3	$1.45M	Hold	150,000	–	–	0.05%	308
2021 Q2	$1.45M	Buy	+150,000	New	+$1.47M	0.05%	284

Fir Tree Capital Management's EBAC Position: Q1 2023 in Review

Fir Tree Capital Management sold out of European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) in Q1 2023, closing a stake of 106,300 shares — an estimated $1.07M sold.

Fir Tree Capital Management first reported a position in EBAC in Q2 2021 and held it in 7 quarters. The position peaked at $1.46M in Q1 2022. 0 funds tracked by Wall St. Rank hold EBAC as of Q1 2023.

Fir Tree Capital Management reported no remaining European Biotech Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Fir Tree Capital Management sold 106,300 European Biotech Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $1.07M.
Fir Tree Capital Management first reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares in Q2 2021 and held it in 7 quarters.
Fir Tree Capital Management's European Biotech Acquisition Corp. Class A Ordinary Shares position peaked at $1.46M in Q1 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on Fir Tree Capital Management's 13F filing for Q1 2023, filed 15 May 2023.